Minnetronix Medical Awarded National Institutes of Health Grant for Proprietary Neurapheresis Product that Removes Blood from Spinal Fluid
October 20, 2020 - Minnetronix Medical, Inc.
Fast Track Small Business Innovation Research Funding Accelerates Minnetronix’s Platform Strategy to Bring Adaptable Technology and Market-Ready Products to Customers
Minnetronix Medical Gets FDA Clearance on Innovative Neurosurgical Access Platform
September 9, 2020 - Minnetronix Medical, Inc.
Medical technology company expands on 25 years of experience with new portfolio of neuro devices, including expandable port for deep brain access.
Minnetronix Neuro inks Neurapheresis Consortium deal with Duke
October 9, 2018 - Medical Design & Outsourcing Magazine
Minnetronix Medical’s Neuro division said today it joined with Duke University to co-found The Neurapheresis Consortium, which aims to accelerate the advancement of Neurapheresis Therapy intended to treat patients with diseases affecting the central nervous system.
Minnetronix Neuro Launches Global Neurapheresis™ Research Consortium
October 8, 2018 - Minnetronix Neuro, Inc.
Collaborative effort will accelerate development of novel therapies for underserved diseases involving the central nervous system
Minnetronix Neuro Successfully Completes First Clinical Study in Hemorrhagic Stroke
October 1, 2018 - Minnetronix Neuro, Inc.
Minnesota-based Company to Present at Late Breaking Session during Congress of Neurological Surgeons...